# Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy

> **NCT03206645** · PHASE1 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 27 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Unesbulin

## Key facts

- **NCT ID:** NCT03206645
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-28
- **Primary completion:** 2021-08-11
- **Final completion:** 2024-03-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2024-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03206645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03206645, "Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03206645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*